Q-omics provides the consensus-scored CDH12P4 profile across patient tissues and cancer cell-line models. CDH12P4 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, CDH12P4 RNA expression shows 1,700 significant pathway-activity associations, with the highest sampling consensus in BRCA. Together, these results highlight MESO, and BRCA as cancer lineages where CDH12P4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.